LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order, SPE2DP26F7479, to DMS PHARMACEUTICAL GROUP INC under the basic contract SPE2DX25D9900 for the supply of one unit of LORATADINE TABLETS, identified by NSN 6505013770448, at a total price of twenty dollars and one cent. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to the destination address at 1 MINUTEMAN WAY, CONCORD NH 03301-0000, US, under FOB destination terms, meaning the contractor assumes full responsibility for freight and risk of loss until delivery. Packaging must use traceable shipping methods, prohibit parcel post, and clearly mark all items with identifying numbers including W51JPA61110053, RDD 111, PROJ TP 2, and the applicable NDC codes. The product must conform to U.S. Pharmacopeia standards and federal pharmaceutical regulations. The contractor is a certified small business, women-owned small business, and small disadvantaged business, triggering specific compliance obligations under FAR clauses related to socioeconomic programs. Payment will be processed through the Defense Finance and Accounting Service with remittance to P.O. Box 182317, Columbus, OH 43218-2317 using the SL4701 payment code and accounting data 97X4930 5CBX 001 2620 S33189. Contract administration is managed by Lisa Quinn as the contracting officer and Shairy M. Cartagena as the administrative support, with no designated COR/COTR identified. The contract contains no options, variance allowances, or explicitly enumerated FAR clauses beyond incorporation by reference of the base contract terms, and no attachments or special requirements beyond packaging and delivery instructions are specified. Inspection and acceptance occur at the destination by the government, with no alternative receiving locations required unless specified, and no barcoding or MIL-STD requirements beyond the provided labeling details.